solid tumor therapeutics
As a member you will be connected with researchers across the cancer continuum, from basic science through public health, and across all UCSD schools, SDSU and La Jolla institute. Learn more about funding opportunities and other member resources today.
Neoantigen-specific stem cell memory-like CD4+ T cells mediate CD8+ T cell-dependent immunotherapy of MHC class II-negative solid tumors
ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis
The development of safe and effective therapeutic and diagnostic agents and the strategies to guide their use is essential to improving the care of cancer patients in our catchment area and beyond.